OICS v0.3.3 class · Healthcare

Generics & Consumer Health

ID GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies1,257 Listed with filings865

Largest first Name Country

Counted by primary class: every company classified here, including delisted companies and companies without filings.

Company	Ticker	Country	Market cap
Sunrest Lifescience Ltd-RE	SUNREST-RE	India	—
Tallinna Farmaatsiatehas Delisted	TFA1T	Estonia	—
Zentiva NV Delisted	—	Netherlands	—
Zillion Pharmachem Ltd. Delisted	ZILLOPH	India	—
БАЛКАНФАРМА - ДУПНИЦА АД Delisted	—	Bulgaria	—
БАЛКАНФАРМА - ТРОЯН АД Delisted	—	Bulgaria	—
ЗАВЕТ АД Delisted	ZAVET	Bulgaria	—

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

genericsOTCAPI manufacturerbiosimilars

Not here

makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Sent here from

Other classes in Pharmaceuticals

Branded Prescription Drugs RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Also big pharma, innovative pharmaceuticals, animal health

Not here no approved product → CLB Clinical-Stage Biotech
Not here approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
Not here mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Permanent link

https://financialfilings.com/oics/GNX/

This page is keyed by the class ID GNX. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard